Why are you posting this everywhere when the PR cl
Post# of 144745
Quote:
CytoDyn plans to seek FDA approval for leronlimab in combination therapy and plans to complete the filing of a Biologics License Application (BLA) in the first quarter of 2020 for that indication.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)